Related Experiment Video
Updated: May 23, 2026

07:49
Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
Published on: July 17, 2019
Marked genetic differences between BRAF and NRAS mutated primary melanomas as revealed by array comparative genomic
Viktória Lázár1, Szilvia Ecsedi, Laura Vízkeleti
1Department of Preventive Medicine, Faculty of Public Health, University of Debrecen, Debrecen, Hungary.
Melanoma Research
|March 30, 2012
Summary
Melanoma progression involves more than BRAF or NRAS mutations. Genomic imbalances differ between BRAF and NRAS mutated melanomas, suggesting distinct cooperating oncogenic events drive tumor development.
Area of Science:
- Genomics
- Oncology
- Molecular Biology
Background:
- Somatic mutations in BRAF and NRAS oncogenes are early events in melanoma initiation.
- These mutations alone are insufficient for melanoma tumor progression.
Purpose of the Study:
- To investigate distinct genomic imbalances in primary melanomas with different BRAF or NRAS genotypes.
- To identify commonly co-occurring genomic regions in different melanoma subgroups.
Main Methods:
- Array comparative genomic hybridization (aCGH) for copy number changes in 47 primary melanomas.
- BRAF and NRAS mutation screening using melting curve analysis.
- Reverse transcription PCR and fluorescence in-situ hybridization for result confirmation.
Main Results:
- Distinct genomic profiles were observed between BRAF and NRAS mutated melanomas.
- BRAF-mutated melanomas showed more frequent losses on 10q23-q26 and gains on chromosome 7 and 1q23-q25.
- NRAS-mutated melanomas frequently exhibited loss on 11q23-q25; those without BRAF/NRAS mutations had alterations in chromosomes 17 and 4.
- Random forest analysis identified 15 classifiers for BRAF mutation with 87% prediction accuracy.
- Extensive alterations in EGF/MAPK-JAK pathways were noted in BRAF-mutated melanomas.
Conclusions:
- Significant genetic pattern differences exist between BRAF and NRAS mutated melanoma subgroups.
- These distinct genetic profiles suggest cooperating oncogenic events contribute to malignant melanoma development alongside BRAF or NRAS mutations.
Related Concept Videos
The Ras Gene
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Ras is a superfamily...
DNA Microarrays
Microarrays are high-throughput and relatively inexpensive assays that can be automated to analyze large quantities of data at a time. They are used in genome-wide studies to compare gene or protein expression under two varied conditions, such as healthy and diseased states. Microarrays consist of glass or silica slides on which probe molecules are covalently attached through surface functionalization. Most commonly, the slides are prepared through the chemisorption of silanes to silica...
MAPK Signaling Cascades
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The Ras Gene
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Ras is a superfamily...
